Tools & Technology
The latest news on life science tools and technology in genetics, genomics, and molecular diagnostics.
Foundation Medicine Assay Nabs FDA Approval as CDx for Ojemda in Pediatric Patients
The FoundationOne test can be used to identify patients with relapsed or refractory BRAF-altered pediatric low-grade glioma who may be eligible for therapeutic options.
Caris Life Sciences, Ontada Ink Deal to Integrate Genomic, Clinical Cancer Data
The firms will combine Caris' multimodal genomic data with Ontada's community oncology-based real-world data to support cancer drug development.
Biden Cancer Moonshot Announces New Initiatives to Improve Diagnosis, Precision Treatments
The program announced a series of new public and private initiatives and projects designed to support its stated goal of halving the cancer death rate over the next 25 years.
NeoGenomics, Adaptive Biotech Partner to Offer Combined Blood Cancer Testing
Doctors ordering NeoGenomics Compass test packages will have the option of including Adaptive's ClonoSeq minimal residual disease assay.
Scipher Medicine, Roivant Partner on Rheumatology Drug Discovery
Roivant will integrate data derived from the development and commercialization of Scipher's PrismRA molecular test to inform its drug development pipeline.